Stay updated on Safety of CVL-231 in Schizophrenia: Clinical Trial

Sign up to get notified when there's something new on the Safety of CVL-231 in Schizophrenia: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of CVL-231 in Schizophrenia: Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.1%
    Check dated 2025-06-13T16:23:02.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-06T09:54:14.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-30T04:47:04.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.2%
    Check dated 2025-05-23T02:03:27.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:09:48.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page has undergone significant content removal, particularly regarding the details of a clinical trial for emraclidine in schizophrenia, including the study's purpose, inclusion and exclusion criteria, and the previous version's revision number. The only notable addition is a new revision number.
    Difference
    23%
    Check dated 2025-04-16T17:40:12.000Z thumbnail image

Stay in the know with updates to Safety of CVL-231 in Schizophrenia: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of CVL-231 in Schizophrenia: Clinical Trial page.